Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Pneumococcal Polysaccharide Vaccination Does Not Reduce Rates of Cardiovascular Events | Pharmacy Times - Pharmacy Practice News and Expert Insights

Summary by Pharmacy Times
Vaccination with 23-valent pneumococcal polysaccharide vaccine did not reduce the rates of acute coronary syndrome and ischemic stroke in a randomized clinical trial.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Pharmacy TimesPharmacy Times

Pneumococcal Polysaccharide Vaccination Does Not Reduce Rates of Cardiovascular Events | Pharmacy Times - Pharmacy Practice News and Expert Insights

Vaccination with 23-valent pneumococcal polysaccharide vaccine did not reduce the rates of acute coronary syndrome and ischemic stroke in a randomized clinical trial.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmacy Times broke the news in on Wednesday, October 8, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccinations icon

Vaccinations

News
For You
SearchBlindspotLocal